Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28541499 | 0.87 | ALDH1A1 (0.35) | ALDH1A1HSD17B10 | |
| SCHEMBL28299925 | 0.86 | QPCT (0.35) | ALDH1A1HSD17B10 | |
| SCHEMBL27122607 | 0.85 | ALDH1A1 (0.34) | ALDH1A1HSD17B10 | |
| SCHEMBL28121892 | 0.84 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL27787556 | 0.83 | TAAR1 (0.35) | HSD17B10 | |
| SCHEMBL5050049 | 0.80 | — | — | |
| SCHEMBL28186501 | 0.79 | — | — | |
| SCHEMBL27618213 | 0.79 | — | — | |
| SCHEMBL2141057 | 0.79 | MAOA (0.39) | ALDH1A1HSD17B10 | |
| SCHEMBL28009257 | 0.79 | ALDH1A1 (0.31) | ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103242411-A | Preparation method and application of novel cholalic acid-porphyrin conjugate | INST BIOMEDICAL ENG CAMS | 2013-08-14 | — | — | CN | claimed |
| CN-103242411-A | Preparation method and application of novel cholalic acid-porphyrin conjugate | INST BIOMEDICAL ENG CAMS | 2013-08-14 | — | — | CN | disclosed |
| US-20030203888-A1 | Chromophores | WELLCOME TRUST LIMITED, THE (GB) | 2003-10-30 | — | — | US | disclosed |
| EP-1294726-A2 | IMPROVEMENTS IN AND RELATING TO CHROMOPHORES | Catalyst Biomedica Ltd (GB) | 2003-03-26 | — | — | EP | disclosed |
| WO-2002000662-A1 | IMPROVEMENTS IN AND RELATING TO CHROMOPHORES | CATALYST BIOMEDICA LIMITED (GB) | 2002-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203888-A1 | Chromophores | HCCS, PPOX, HMBS | ALDH1A1 2976/4885HSD17B10 625/4885DHFR 113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.